Glaukos
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
GKOS Key Statistics
Stock Snapshot
As of today, Glaukos(GKOS) shares are valued at $121.44. The company's market cap stands at 7.05B, with a P/E ratio of -37.12.
On 2026-02-27, Glaukos(GKOS) stock opened at $121.92, reached a high of —, and a low of —.
Glaukos(GKOS) shares are trading with a volume of 0, against a daily average of 868.45K.
In the last year, Glaukos(GKOS) shares hit a 52-week high of $130.23 and a 52-week low of $73.16.
In the last year, Glaukos(GKOS) shares hit a 52-week high of $130.23 and a 52-week low of $73.16.
GKOS News
New insider activity at Glaukos ( (GKOS) ) has taken place on February 23, 2026. Glaukos director Aimee Weisner has executed a notable insider transaction, sel...
In February 2026, Glaukos Corporation reported fourth-quarter 2025 sales of US$143.12 million and full-year sales of US$507.44 million, alongside a US$112.87 mi...
Analyst ratings
88%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.